Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials
Assis DN, Levy C. Oral Vancomycin or Ursodeoxycholic Acid for Pediatric Primary Sclerosing Cholangitis? The Uncontroversial Need for Randomized Controlled Trials. Hepatology 2021, 73: 887-889. PMID: 33403699, DOI: 10.1002/hep.31702.Peer-Reviewed Original ResearchConceptsPediatric Primary Sclerosing CholangitisPrimary sclerosing cholangitisRandomized Controlled TrialsOral vancomycinSclerosing cholangitisControlled TrialsUrsodeoxycholic acidCholangitisVancomycinTrials